GlassScriptPhysician profile
Steven Gannon
NPI 1265877195
$558.21
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $127 · 2021: $107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $116.49 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $106.63 | 2021 | |
| Mallinckrodt Enterprises LLC | $77.42 | 2019 | |
| Allergan, INC. | $59.02 | 2019 | |
| Csl Behring | $47.23 | 2019-2020 | |
| Pfizer INC. | $39.29 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.31 | 2020 | |
| Acera Surgical, INC. | $17.58 | 2020 | |
| Portola Pharmaceuticals, LLC | $16.71 | 2019 | |
| Cook Medical LLC | $16.01 | 2019 | |
| Shire North American Group INC | $15.70 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.43 | 2019 | |
| Kci USA, INC. | $12.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.